Harlequin Ichthyosis: A Rare Skin Disorder

Pooja Palandurkar *

Dr. D.Y. Patil College of Pharmacy, Akurdi, Pune, India.

Doulisa Jain

Dr. D.Y. Patil College of Pharmacy, Akurdi, Pune, India.

Pavankumar Wankhade

Dr. D.Y. Patil College of Pharmacy, Akurdi, Pune, India.

*Author to whom correspondence should be addressed.


Harlequin ichthyosis, an exceptionally rare and severe genetic skin disorder, presents a unique intersection of genetics, skin biology, and clinical manifestation. This congenital condition, a severe form of ichthyosis, has captivated the medical community due to its striking clinical features. It arises from genetic mutations in the ABCA12 gene, disrupting skin barrier formation. The clinical presentation is characterized by diamond-shaped scales, facial distortions, and medical challenges, particularly in neonates. Historical accounts have contributed to our evolving understanding, culminating in recent genetic advancements. While no cure exists, treatment involves a combination of medical interventions and supportive care. The psychosocial impact on affected individuals and families is profound. Despite challenges, the future is promising, driven by genomics, precision medicine, novel therapies, and collaborative research. Harlequin ichthyosis represents a remarkable example of progress at the intersection of science and compassion.

Keywords: Harlequin ichthyosis, genetic mutation, congenital disorder

How to Cite

Palandurkar, Pooja, Doulisa Jain, and Pavankumar Wankhade. 2023. “Harlequin Ichthyosis: A Rare Skin Disorder”. Journal of Advances in Medical and Pharmaceutical Sciences 25 (11):1-7. https://doi.org/10.9734/jamps/2023/v25i11649.


Download data is not yet available.


Valerio E, Barlotta A, Lorenzon E, Antonazzo L, Cutrone M. Harlequin color change: Neonatal case series and brief literature review. AJP Rep. 2015 Apr;5(1):e73-6.

Tsuboi K, Tsuboi N, Nosaka N, Nishimura N, Nakagawa S. Neonatal harlequin color change associated with Prostaglandin E1 administration. Pediatr Int. 2021 May;63(5):610-611.

Grall A, Guaguère E, Planchais S et al. PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans. Nat Genet. 2012;44(2):140-147.

Akiyama M. Harlequin ichthyosis and other autosomal recessive congenital ichthyoses: The underlying genetic defects and pathomechanisms. J Dermatol Sci. 2006;42(2):83-89.

Elias PM, Williams ML, Holleran WM, et al. Pathogenesis of permeability barrier abnormalities in the ichthyoses: Inherited disorders of lipid metabolism. J Lipid Res. 2008;49(4):697-714.

Elias PM, Williams ML, Holleran WM et al. Pathogenesis of permeability barrier abnormalities in the ichthyoses: Inherited disorders of lipid metabolism. J Lipid Res. 2008;49(4):697-714.

Cheshire WP, Low PA. Harlequin syndrome: Still only half understood. J Neuro ophthalmol. 2008 Sep;28(3):169-70.

Carroll CB, Zajicek JP. The 'harlequin' sign in association with multiple sclerosis. J Neurol. 2004 Sep;251(9):1145-6.

Oji V, Tadini G, Akiyama M et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol. 2010;63(4):607-641.

Fischer J. Autosomal recessive congenital ichthyosis. Journal of Investigative Dermatology. 2009;129(6):1319–1321. DOI:10.1038/jid.2009.72

Hackett CB, Lee HJ. Prenatal diagnosis of harlequin ichthyosis using a targeted next‐generation sequencing panel. Pediatric Dermatology. 2017;34(3):e172–e174. DOI:10.1111/pde.13123

Vahlquist A, Bygum A, Gånemo A, Virtanen M, Hellström‐Pigg M, Strauss G, Brandrup F. Genotypic and clinical spectrum of self‐improving collodion ichthyosis: ALOX12B, ALOXE3, and TGM1 mutations in Scandinavian patients. Journal of Investigative Dermatology. 2018;138(2): 421–429. DOI:10.1016/j.jid.2017.09.013

Rajpopat S, Moss C, Mellerio J, Vahlquist A, Gånemo A, Hellström‐Pigg M, …McGrath J. Harlequin ichthyosis: A review of clinical and molecular findings in 45 cases. Archives of Dermatology. 2011;147(6):681–686. DOI:10.1001/archdermatol.2011.40

Vahidnezhad H, Youssefian L, Saeidian AH, Zeinali S, Sotoudeh S, Uitto J. Harlequin ichthyosis, a systematic review of therapeutic outcome reports and an analysis of patient‐derived data. Journal of Dermatological Treatment. 2017;29(5): 470–475. DOI:10.1080/09546634.2017.1318344

Judge MR, McLean WH, Munro CS. Disorders of Keratinization. In Rook's Textbook of Dermatology (8th ed.). 2005;19.1:19.73. John Wiley &Sons.

Wilson J, Fisher R, Caetano F, Soliman-Aboumarie H, Patel B, Ledot S, Price SV, Enbriele C. Managing harlequin syndrome in VA-ECMO -do not forget the right ventricle. Perfusion. 2022 Jul;37(5): 526-529.